Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells.

J Vis Exp

Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration;

Published: September 2018

Automated microscale bioreactors (15 mL) can be a useful tool for cell culture engineers. They facilitate the simultaneous execution of a wide variety of experimental conditions while minimizing potential process variability. Applications of this approach include: clone screening, temperature and pH shifts, media and supplement optimization. Furthermore, the small reactor volumes are conducive to large Design of Experiments that investigate a wide range of conditions. This allows upstream processes to be significantly optimized before scale-up where experimentation is more limited in scope due to time and economic constraints. Automated microscale bioreactor systems offer various advantages over traditional small scale cell culture units, such as shake flasks or spinner flasks. However, during pilot scale process development significant care must be taken to ensure that these advantages are realized. When run with care, the system can enable high level automation, can be programmed to run DOE's with a higher number of variables and can reduce sampling time when integrated with a nutrient analyzer or cell counter. Integration of the expert-derived heuristics presented here, with current automated microscale bioreactor experiments can minimize common pitfalls that hinder meaningful results. In the extreme, failure to adhere to the principles laid out here can lead to equipment damage that requires expensive repairs. Furthermore, the microbioreactor systems have small culture volumes making characterization of cell culture conditions difficult. The number and amount of samples taken in-process in batch mode culture is limited as operating volumes cannot fall below 10 mL. This method will discuss the benefits and drawbacks of microscale bioreactor systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235343PMC
http://dx.doi.org/10.3791/58231DOI Listing

Publication Analysis

Top Keywords

automated microscale
12
cell culture
12
microscale bioreactor
12
bioreactor systems
8
culture
5
high-throughput automated
4
automated microbioreactor
4
microbioreactor system
4
system production
4
production model
4

Similar Publications

Breast tumors are typically surrounded by extracellular matrix (ECM) that is heterogeneous, not just structurally but also mechanically. Conventional rheometry is inadequate for describing cell-size-level spatial differences in ECM mechanics that are evident at micrometer scales. Optical tweezers and passive microrheometry provide a microscale resolution for the purpose but are incapable of measuring ECM viscoelasticity (the liquid-like viscous and solid-like elastic characteristics) at stiffness levels as found in breast-tumor biopsies.

View Article and Find Full Text PDF

Self-assembly of 1T/1H superlattices in transition metal dichalcogenides.

Nat Commun

December 2024

International Center for Quantum Design of Functional Materials (ICQD), Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, Anhui, 23026, China.

Heterostructures and superlattices composed of layered transition metal dichalcogenides (TMDs), celebrated for their superior emergent properties over individual components, offer significant promise for the development of multifunctional electronic devices. However, conventional fabrication techniques for these structures depend on layer-by-layer artificial construction and are hindered by their complexity and inefficiency. Herein, we introduce a universal strategy for the automated synthesis of TMD superlattice single crystals through self-assembly, exemplified by the NbSeTe 1T/1H superlattice.

View Article and Find Full Text PDF

Multipath Projection Stereolithography for Three-Dimensional Printing Microfluidic Devices.

ACS Appl Mater Interfaces

December 2024

Department of Biomedical and Chemical Engineering, Syracuse University, 900 S Crouse Avenue, Syracuse, New York 13244, United States.

Although many lab-on-chip applications require inch-sized devices with microscale feature resolution, achieving this via current 3D printing methods remains challenging due to inherent trade-offs between print resolution, design complexity, and build sizes. Inspired by microscopes that can switch objectives to achieve multiscale imaging, we report a new optical printer coined multipath projection stereolithography (MPS) specifically designed for printing microfluidic devices. MPS is designed to switch between high-resolution (1× mode, ∼10 μm) and low-resolution (3× mode, ∼30 μm) optical paths to generate centimeter-sized constructs (3 × 6 cm) with a feature resolution of ∼10 μm.

View Article and Find Full Text PDF

Emerging Trends in Integrated Digital Microfluidic Platforms for Next-Generation Immunoassays.

Micromachines (Basel)

November 2024

Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

Technologies based on digital microfluidics (DMF) have made significant advancements in the automated manipulation of microscale liquids and complex multistep processes. Due to their numerous benefits, such as automation, speed, cost-effectiveness, and minimal sample volume requirements, these systems are particularly well suited for immunoassays. In this review, an overview is provided of diverse DMF manipulation platforms and their applications in immunological analysis.

View Article and Find Full Text PDF

Automating life science labs at the single-cell level through precise ultrasonic liquid sample ejection: PULSE.

Microsyst Nanoeng

November 2024

Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 27708, USA.

Laboratory automation technologies have revolutionized biomedical research. However, the availability of automation solutions at the single-cell level remains scarce, primarily owing to the inherent challenges of handling cells with such small dimensions in a precise, biocompatible manner. Here, we present a single-cell-level laboratory automation solution that configures various experiments onto standardized, microscale test-tube matrices via our precise ultrasonic liquid sample ejection technology, known as PULSE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!